FDA
-
-
-
-
-
-
-
IceCure cites journal article on cryoablation vs. RFA for breast cancer
-
-
-
-
-
-
-
IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America
-
-
-
-
-
-
-
FDA approves IceCure post-market study for breast cancer treatment device
-
-
-
-
-
-
-
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense®
-
-
-
-
-
-
-
IceCure Medical studies presented at radiology conference
-
-
-
-
-
-
-
IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction
-
-
-
-
-
-
-
IceCure receives FDA approval for breast cancer cryoablation device
-
326,854 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

